Bell Investment Advisors, Inc Global Blood Therapeutics, Inc. Transaction History

Bell Investment Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$32.4 - $68.18 $226 - $477	7 New	7 $0
Q2 2022 Aug 12, 2022	SELL	$22.3 - $37.39 $401 - $673	-18 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $423 - $684	-17 Reduced 48.57%	18 $1,000
Q3 2021 Nov 12, 2021	BUY	$25.48 - $37.34 $891 - $1,306	35 New	35 $1,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Bell Investment Advisors, Inc with notifications on news.